We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
101
Otis Worldwide
OTIS
$27.9B
$40.8M 0.26%
468,402
+96,737
+26% +$8.1M
AMBA icon
102
Ambarella
AMBA
$2.99B
$40.6M 0.26%
200,097
+3,510
+2% +$651K
TTEK icon
103
Tetra Tech
TTEK
$8.28B
$40M 0.26%
1,178,010
-153,465
-12% -$5.29M
CCI icon
104
Crown Castle
CCI
$32.4B
$39.9M 0.25%
191,344
+7,819
+4% +$1.44M
AXP icon
105
American Express
AXP
$226B
$39.9M 0.25%
243,631
+168,393
+224% +$28.7M
ADP icon
106
Automatic Data Processing
ADP
$102B
$38M 0.24%
153,918
+7,654
+5% +$1.73M
BPMC
107
DELISTED
Blueprint Medicines
BPMC
$37.7M 0.24%
352,243
+39,293
+13% +$4.11M
TGT icon
108
Target
TGT
$63.7B
$37.7M 0.24%
162,766
+17,562
+12% +$4.27M
MMM icon
109
3M
MMM
$91.9B
$37.2M 0.24%
250,141
+18,118
+8% +$2.7M
INFO
110
DELISTED
IHS Markit Ltd. Common Shares
INFO
$36.4M 0.23%
274,011
-1,598
-0.6% -$203K
MDLZ icon
111
Mondelez International
MDLZ
$77.9B
$36.2M 0.23%
546,627
-10,877
-2% -$671K
INTC icon
112
Intel
INTC
$462B
$35.9M 0.23%
697,919
+166,212
+31% +$8.5M
OLED icon
113
Universal Display
OLED
$3.81B
$35.9M 0.23%
217,657
+1,454
+0.7% +$240K
IPG
114
DELISTED
Interpublic Group of Companies
IPG
$35.5M 0.23%
948,304
-22,013
-2% -$800K
TECH icon
115
Bio-Techne
TECH
$11.2B
$35.4M 0.23%
273,844
+56,380
+26% +$6.91M
IDXX icon
116
Idexx Laboratories
IDXX
$43.9B
$35.3M 0.23%
53,645
+9,819
+22% +$6.16M
ITOS
117
DELISTED
iTeos Therapeutics
ITOS
$35.3M 0.23%
757,327
+232,083
+44% +$7.73M
EA icon
118
Electronic Arts
EA
$52.4B
$34.9M 0.22%
264,447
+197,665
+296% +$26.6M
CVS icon
119
CVS Health
CVS
$137B
$34.8M 0.22%
336,984
+1,686
+0.5% +$156K
BRK.B icon
120
Berkshire Hathaway Class B
BRK.B
$1.07T
$34.6M 0.22%
115,801
-9,381
-7% -$2.69M
AFL icon
121
Aflac
AFL
$64.4B
$34.2M 0.22%
585,348
+175,609
+43% +$9.84M
XNCR icon
122
Xencor
XNCR
$1.47B
$33.4M 0.21%
831,339
+193,539
+30% +$7.34M
APLS
123
DELISTED
Apellis Pharmaceuticals
APLS
$32.8M 0.21%
694,425
+439,395
+172% +$17.3M
INVH icon
124
Invitation Homes
INVH
$17.6B
$32.7M 0.21%
721,641
+211,236
+41% +$8.73M
VRNS icon
125
Varonis Systems
VRNS
$5.36B
$32.5M 0.21%
665,722
+11,515
+2% +$656K
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.